Related Experiment Video
Updated: Dec 30, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Markovian approach to tackle the interaction of simultaneous diseases
D Soriano-Paños1,2, F Ghanbarnejad3,4,5, S Meloni6
1GOTHAM Laboratory, Institute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, 50018 Zaragoza, Spain.
Abstract:
The simultaneous emergence of several abrupt disease outbreaks or the extinction of some serotypes of multistrain diseases are fingerprints of the interaction between pathogens spreading within the same population. Here, we propose a general and versatile benchmark to address the unfolding of both cooperative and competitive interacting diseases. We characterize the explosive transitions between the disease-free and the epidemic regimes arising from the cooperation between pathogens and show the critical degree of cooperation needed for the onset of such abrupt transitions. For the competing diseases, we characterize the mutually exclusive case and derive analytically the transition point between the full-dominance phase, in which only one pathogen propagates, and the coexistence regime. Finally, we use this framework to analyze the behavior of the former transition point as the competition between pathogens is relaxed.
Insights
This study introduces a new model for understanding how interacting diseases, both cooperative and competitive, spread within populations. It identifies critical factors for abrupt disease outbreaks and analyzes pathogen competition dynamics.
Area of Science:
- Epidemiology
- Mathematical Biology
- Disease Dynamics
Background:
- Interactions between pathogens, such as cooperation or competition, influence disease outbreaks and pathogen coexistence.
- Understanding these complex dynamics is crucial for predicting and controlling infectious diseases in populations.
Purpose of the Study:
- To develop a general and versatile benchmark for studying cooperative and competitive interacting diseases.
- To characterize explosive transitions in disease-free and epidemic regimes due to pathogen cooperation.
- To analytically derive the transition point between pathogen dominance and coexistence in competing disease scenarios.
Main Methods:
- Development of a general benchmark model for interacting disease dynamics.
- Characterization of explosive transitions using mathematical analysis.
- Analytical derivation of transition points for competing pathogens.
Main Results:
- Identified critical degrees of cooperation leading to abrupt disease transitions.
- Characterized the mutually exclusive case for competing diseases.
- Derived the analytical transition point between single pathogen dominance and coexistence regimes.
Conclusions:
- The proposed benchmark provides a framework for analyzing complex pathogen interactions.
- Understanding cooperation is key to predicting abrupt disease outbreaks.
- The framework allows for the analysis of disease dynamics as competition levels change.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
Related Concept Videos
Causality in Epidemiology
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Principles of Disease Surveillance